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Summary 
Dendritic  cells isolated from thymus and tonsil were tested for susceptibility to HIV-1 strains 
that are tropic for macrophages or for T  cell lines. DCs were purified by cell sorting and before 
infection expressed high levels of CD4 and HLA-DR and lacked markers for T, B, NK cells, 
or macrophages. Viral entry and reverse transcription was found after pulsing with strains of 
HIV-1 that could infect macrophages. During the first 36 h the PCR signals for gag sequences 
increased in DCs and macrophages. In contrast litde if any viral DNA was found after pulsing 
macrophages or DCs with HIV-1 that was able to infect T  cell lines. DCs pulsed with HIV-1 
were able to transmit infection to responding T  cells during an allogeneic or superantigen re- 
sponse. 
Selection for virus able to infect lymphoid DCs and other DCs expressing CD4 and its trans- 
fer to T  cells during subsequent immune responses may provide a mechanism for the observed 
predominance ofmacrophage-tropic HIV-1 after in vivo transmission. 
D 
endritic cells  (DCs) 1 are leukocytes specialized for an- 
tigen processing and presentation to T  cells  (1).  Ab- 
normalities of antigen presentation that may be attributable 
to  dysfunction  of DCs  have  been  reported  in  HIV-1- 
infected individuals (2-4). Such abnormalities increase dur- 
ing the course of the disease, but it remains unclear whether 
these changes are directly due to infection of the DCs (5) 
or to indirect viral effects that are independent  of DC in- 
fection.  Defective proliferative responses  during  the  cog- 
nate  interaction  of T  cells  with virus-pulsed DCs  (6)  oc- 
curs, but frequent infection of the DCs is not required (7). 
Estimates  of virus  susceptibility  of  isolated  DCs  and 
Langerhans cells (LCs) have varied widely. Productive in- 
fection has been reported in some but not all the studies of 
blood DCs (6, 8-13) although cultured DC-enriched pop- 
ulations  rather  than  purified  DCs  have  often  been  used. 
Differences in the DC phenotype and the composition of 
the DC-enriched fraction used as targets, in particular dif- 
ferences  in  CD4  expression,  may  explain  differences  in 
HIV-1  susceptibility.  The  reduced  density  of  cukured 
blood  DCs  facilitates  enrichment  (14--16),  but  cultured 
1Abbreviations used in this paper: DC, dendritic cells; KT, reverse tran- 
scriptase; SI, Syncytia  inducing; NSI, non-syncytia  inducing; MOI, mul- 
tiplicity of infection; NHS, normal human serum. 
blood DCs express little if any CD4 (8,  16).  Two popula- 
tions of fresh blood DCs strongly express CD4 (17, 18), but 
after culture and functional maturation CD4 is lost (16, 17). 
To better define the role of CD4 and the extent of HIV-1 
entry into DCs from sites in which immune responses oc- 
cur in vivo we examined the susceptibility of sorted DCs 
from lymphoid tissue. Cultured tonsil DCs are potent anti- 
gen-presenting cells (APCs) (19, 20) that express costimula- 
tot molecules (20) and continue to express CD4 in culture 
(19).  Functionally they resemble cultured blood DCs (16). 
Thymic cells isolated directly without culture express high 
levels of CD4 and function  as potent APCs  (21,  22).  We 
now  show  that  the  functionally mature  CD4 +  lymphoid 
DCs from both tonsil and thymus can be infected by HIV-1, 
but there is preferential entry of virus that is able to infect 
macrophages. 
Materials and Methods 
Isolation of Primary Cells.  Thymic DCs  were  obtained  using 
the method of Winkel et aL (22). Human thymus (neonatal-11 
yr) discarded during cardiac surgery was used. Thymus was stored 
on ice during transport  and was processed the same day (usuaUy 
within 8 h).  Tissue was carefully dissected, suspended  in  15 ml 
RPMI-1640  (+2% FCS) containing  2 mg/ml coUagenase (type 
II; Worthington  Biochemicals,  Freehold,  NJ)  and  0.02  mg/ml 
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helm, Mannheim, Germany) and digested for 20-30 rain at 22~ 
1.5 rnl EDTA (100 raM, pH 7.2)  was added for 5 rain and cells 
were filtered through  a steel sieve (80-100  gauge; Swiss screens, 
Sydney, Australia). Ceils were pelleted, suspended in isotonic me- 
trizamide (d =  1.065  g/m1), and run over a metrizamide cushion 
(d  =  1.065)  at  1600 g  for  10 rain at 4~  Low density cells ex- 
pressing  CD2,  3,  14,  and  19  were  removed  by  labeling  with 
monoclonal antibodies  and  two  rounds  of depletion with mag- 
netic beads (GAM-coated paramagnetic beads; Dynal, Oslo, Nor- 
way).  The  residual  cells  were  labeled  with  FITC-conjugated 
HLA-DR  and  cells  with  high  and  intermediate  expression  of 
HLA-DR  sorted  as  two  separate  populations  using  a  FACStar 
plus (Becton Dickinson, Mountain View, CA). 
Tonsils dendritic cells were obtained using modifications of the 
method described by Hart  and  McKenzie  (19).  Normal  human 
serum (NHS) was used throughout the isolation, and T  cells were 
not specifically removed before culture.  Tonsils were  stored  on 
ice in medium containing 250  btg/nd gentamicin and processed 
within 3 h. The epithelial layer was removed and tissue dissected 
and digested in medium containing 0.5 mg/ml collagenase (type 
II; Worthington)  and 5 I.tg/ml DNase I  (Boehringer Mannheim, 
Mannheim,  Germany)  for 20 n-fin at 37~  EDTA was added for 
5 rain and ceils pelletted and resuspended in isotonic metrizamide 
and then run on a density columns at  1600 g for 10 rain at 4~ 
Cells with a density between 1.040 and 1.065 were collected and 
washed  before  culture  at  3-5  X  106/ml  in  R10  NHS  (RPMI 
1640, gentamicin 25 Ixg/ml, glutamine 2 raM, 2 ME 0.025 raM, 
Hepes  10  raM,  10% NHS) for 36-40  h.  HLA-DR+  cells nega- 
tive for lineage markets (CD3,  14,  19, and 56) were contained in 
the low density fraction.  Low density cells were collected over a 
second metrizamide gradient and labeled with optimal concentra- 
tions ofhybridoma supematants to CD3 (OKT3), CD19 (FMC63), 
CD14  (3C10),  and  CDllb  (OKM1).  Cells were panned  twice 
on dishes coated with sheep anti-mouse Ig antibody  (SAM; Sile- 
nus, Melbourne, Victoria, Australia) at 5  txg/ml. The nonadher- 
ent cells from the antibody pans were labeled with PE conjugated 
SAM (Silenus)  and large PE-negative cells sorted  on a  FACStar 
Plus (Becton Dickinson). 
Monocyte  derived  macrophages  were  plastic  adherent  cells 
cultured for 5-7 d in  10%  human serum.  Cells were cultured in 
R10  NtHS in teflon dishes  (Sariliex, Minnetonka,  MN).  Before 
infection cells were plated in fresh medium for 0.5-1  h  and any 
residual non-adherent cells were removed. 
CD4 + T  cells were purified from elutriated lymphocytes or the 
Er  + fraction ofbuffy coats by negative selection using hybridoma 
supernatants  to  CD8  (OKTS),  CD19  (FMC63),  and  HLA-DR 
(FMC 52)  and panning on SAM-coated plates. 
The T  cells lines CEM-T4, MT-2, and the cell line 8E5  that 
contains a single defective copy of HIV-I per cell, were grown in 
R10  FCS  and  passaged  twice weekly.  Cell lines were  obtained 
through  the  AIDS  Research  and  Reference  Reagent  Program, 
Division of AIDS, NIAID, NIH. 
Virus Culture and Infection.  Low  passage  patient  isolates  228 
(syncytium-inducing  [SI]  phenotype  in  MT-2  cells)  and  676 
(non-syncytium-inducing  [NSI]  in  MT-2  cells),  the  T  cell line 
tropic  virus  IIIb  and  the  macrophage-tropic  virus  Ba-L  were 
grown in mitogen activated PBMCs.  Isolates IIIb and 228  were 
also  grown in CEM-T4  or MT-2,  and Bal and 676  in cultured 
macrophages.  Virus  stocks  were  stored  at  -70~  and  treated 
with  RNase  free  DNase  I  (50  U/ml,  Boehringer  Mannheim, 
Mannheim  Germany)  for 20  rain  at  22~  and  filtered  (0.2-~m 
filter) before use. 
Target cells were exposed to HIV-I viral supematants for 1.5-2 h 
at  37~  washed  and  cultured  in  T  cell  conditioned  medium. 
Multiplicities  of infection  (MOls)  were  between  0.01  and  0.1. 
For PCR,  cells (50-100  ￿  103  cells per well) were pulsed with 
HIV-1  in microtiter plates for  1.5  h  at 37~  washed once,  and 
then  cultured  in  30%  T  cell conditioned  medium.  Cell lysates 
were harvested after 24-36 h. For transfer experiments DCs were 
pulsed with HIV-1  in eppendorf tubes for 1.5-2 h  before wash- 
ing four times with medium. Washed cells were added to alloge- 
neic T  cells (104 DCs to 1-1.5  X l0 s CD4 + T  cells) immediately 
or after 24 h  culture in T  cell-conditioned medium.  The mixed 
leukocyte reactions  (MLRs)  were performed in triplicate in flat- 
bottomed  microtiter plates  in  RI0  NHS.  Supernatants  for  RT 
analysis were harvested and stored at -70~ 
For AZT blocking the target cells were incubated in medium 






i0  I00  i000 








#iiii  : 
~  . 
Figure  1.  Strongly  HLA-DR-positive sorted  thymic  and  tonsil  DCs 
express high  levels of CD4.  (A)  Low-density  thymic  cells depleted  of 
contaminating  cells by immunomagnetic bead depletion  using CD14, 3, 
2, and 19 were sorted into DR  hi and DR  ~" cells. DR  hi cells (Thymic 1)Cs) 
expressed CDllc and had a typical DC morphology.  DR  l~ cells were het- 
erogeneous for expression of CDI lc. Total DR  l~ and the two subpopula- 
tions  defined  by CDllc were tested  for susceptibility to HIV-1  (DR)  ~ 
cells, Figs. 2, 3). The thymic DCs (and DR  I~ cells) had similar CD4 ex- 
pression to CD4+  thymocytes.  (B) Tonsil DCs expressed high levels of 
HLALDR and  CD4 but did not express lineage-specific markers.  Low- 
density cultured tonsil cells were partially depleted of CD3-, 14-, and 19- 
bearing  cells by panning.  Cells were labeled with PE-SAM and the large 
null cells sorted.  The collected cells were labeled with FITC conjugated 
HLA-DR alone  or with  PE-labeled  CD2,  CD20,  CD;1b,  CD16,  or 
CD4 (FL2). 
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PCR gag template in T blasts, macrophages, and DCs. 
Reverse TranscriptaseAssay.  Reverse  transcriptase  activity  in 
supematants was assayed as previously reported (7).  Filters were 
counted in a microbeta counter with cross-talk correction (Wal- 
lac,Turku, Finland) with Meltilex scintillant (Wallac). 
Semiquantitative PCR.  PCR was performed as previously re- 
ported (7). 
Figure  2.  Lymphoid DCs are preferentially infected by macrophage- 
tropic virus by CD4 dependent mechanisms. (A) Similar numbers of thy- 
mic DCs, cultured macrophges, and CEM were pulsed with IIIb (lane 1), 
Ba-L (lane 2), and YU-2 (lane 3). HIV-1 gag transcripts  were detected by 
PCR after 36 h of culture. Positive control was 104 of the 8E5 cell line 
that carries one provirus per cell and negative controls were cells pulsed 
with virus at 4~  HLA-DQA primers were included in each reaction to 
amplify genomic sequence (upper  bands). (B) Both DR  1~ (lanes 1 and 2) 
and DR hi  (lane 3) thymic DCs were susceptible to virus entry by mac- 
rophage  tropic  isolates. The  thymic  populations negative for  lineage- 
specific markers were  sorted  for  CDIJc  and  HLA-DR.  The  DR  1~ 
CDllc- (lane 1), DR  I~ CDllc+ (lane  2) and DR  hi populations were all 
susceptible to NSI patient isolate 676. Entry into the thymic DCs (DR  hi, 
lane 3) was blocked by sCD4 (lane 4). (C) HIV-1 Ba-L infection ofthy- 
mic DCs (DRhi) was blocked by antibody to CD4 (lane 2, 5 p~g/ml)  and 
by soluble CD4 (lane 3, 50 I-~g/rrfl).  Entry into macrophages was incom- 
pletely blocked  under  the  same conditions.  (D)  Frequency  of HIV-I 
provirus in thymic DCs, tonsil DCs, macrophages, and T cells lines after a 
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Results  and Discussion 
Phenotype  and Infection of Lymphoid DCs  and  Subpopula- 
tions.  In contrast to most previous studies of isolated DCs 
we  have  used  cells that  express high  levels  of CD4.  The 
phenotype  and  function  of the  DR hi  thymic  DCs  have 
been  reported  (21).  Within  the  DR l~ population  of lin- 
eage-negative thymic cells a residual subpopulation became 
plastic  adherent,  but  the  majority  continued  to  express 
CD4, increased DR  expression, and appeared by morphol- 
ogy to be DCs. After overnight culture a single DR hi pop- 
ulation  was  found  (data  not  shown)  suggesting  the  DR 1~ 
cells mainly consists of a  subpopulation of DCs.  Although 
all the DR hi cells expressed CD1 lc, expression in the DR 1~ 
population was heterogenous (Fig. 1 A). Most of the sorted 
tonsil  cells  enriched  for DCs  by sorting for  the  CD14-, 
CD3-  CD19-  large cells expressed high levels of HLA-DR 
and CD4  (Fig.  1 B)  and did not express the markers CD2, 
20,  16,  and  11b,  found on  T, B,  and NK  cells, and mac- 
rophages.  The  DCs  expressed  CD80  (B7/BB1)  but  not 
CDllc,  exhibited a typical dendritic morphology and rap- 
idly formed aggregates of veiled cells (data not shown).  In 
contrast CDllc-  blood DCs were immature and required 
conditioned medium  for maturation  and  survival and lost 
CD4  during culture (16,  17). Levels of CD4 at the time of 
infection were similar in the fresh thymic DCs,  DR l~ thy- 
mic  cells, cultured  tonsil DCs,  and  the  T  cells  (Fig.  1,  A 
and B). 
Viral entry was easily detected by PCR.  HIV-1  gag tran- 
scripts were present after the thymic DCs had been pulsed 
with Ba-L but not with  the  IIIb isolate  (Fig.  2  A).  Entry 
into  the  DCs  was  almost  completely blocked  by  soluble 
CD4 and anti-CD4 antibody (Fig. 2, B and C). Within the 
DR I~ thymic population both the  CDllc+  and CD1 lc- 
subpopulations  were  infected by macrophage  tropic  virus 
(Fig.  2  B),  discounting  macrophage  contamination  as  an 
explanation.  The  number  of copies of macrophage-tropic 
virus in DCs was usually less than in cultured macrophages 
(0.3--0.1)  but almost invariably greater than  in T  cell lines 
(Fig. 2  D). 
The  tropism  of HIV-l-infecting  thymic  DCs  was  of 
particular interest because a  close developmental relation- 
ship to T  cell has been shown in the mouse (23). However, 
this relationship does not extend to susceptibility to SI virus 
since thymic DCs  were no  more susceptible to  the  T  cell 
virus pulse. The number of copies was determined by densitometric com- 
parison of gag signal in the senfiquantitative PCR assay. Mac, cultured 
macrophages; Tcell, CEM-T4 or MT2; ThyDC, thymic DC; toDC, ton- 
sil DC. Figure 3.  Macrophages,  tonsil DCs,  and thymic DCs show similar ki- 
netics of viral entry and tropism.  (A) Macrophages,  Thymic DC and the 
DK  1~ sorted populations  were pulsed with Ba-L and cell lysates harvested 
after different times in culture.  1 =  0, 2 =  12, 3 =  24, 4 =  48 h after vi- 
rus pulse. Controls were PHA blasts. (B) Sorted  tonsil DCs were pulsed 
with Ba-L and Illb strains and infection  compared  to that in thymocytes, 
cultured  macrophages, and the T cell line CEM. PCR for gag and DQA 
sequences was performed at the end of the pulse (0 h, lane  1) after 10 h 
(lane 2), and after 36 h (lane 3) of culture. Increased signal occurred in the 
Ba-L infected DCs and macrophages but not in Illb-infected tonsil DCs. 
Controls  were 8E5 cells (-ve  =  0,  1 =  10, 2  =  100, 3  =  1000, 4  = 
10000 copies of 8E5). 
line-tropic strains  of HIV-1  than  macrophages  using either 
DR hi DCs  or the  DR 1~ immature  DCs  as  targets.  Thymic 
and tonsil DCs were similar in HIV-1  susceptibihty. 
In sorted thymic DCs and permissive cells a  PCK  signal 
for gag was present after  10-12  h  but not at the end of the 
pulse with Ba-L (1.5-2 h)  (Fig. 3, top).  The signal increased 
up to the endpoint  of the analysis  (48 h)  and was compara- 
ble  to  the  signal  found  with  a  similar  number  of Ba-L- 
infected macrophages. 
Sorted  tonsil  DCs,  pulsed  with  virus  and  analyzed  by 
PCR  showed  efficient  entry  by  Ba-L  compared  to  IIIb 
(Fig.  3,  bottom),  With Ba-L, gag increased with time up  to 
the  endpoint  (36  h),  but  little  change  in  gag  occurred  in 
cultures  pulsed with IIIb.  Thymocytes  were  susceptible  to 
HIV-1  as  reported  by  others  (24)  and  were  infected  by 
both isolates, The cell hne CEM  was infected to high levels 
only  by  the  IIIb  isolate.  Infection  of thymic  DCs  in  vivo 
has  been  suggested  by  the  observation  of p24  antigen  in 
cells with  DC  morphology  in  the  implanted  human  thy- 
mus  of SCID-hu-mice  after infection with patient  isolates 
of HIV-1  (24).  Exogenous infection of thymic DC  popula- 
tions was also found  (25)  but the tropism of the the infect- 
ing virus was not defined. 
HI V- 1 Infection and Transfer  fiom DCs to T  Cells.  We have 
previously shown that cultured blood DCs,  although infre- 
quently  infected,  can  carry virus  and  transmit  infection  to 
resting T  cells during stimulation  (6)  or to T  cell hnes dur- 
ing coculture  (26).  Detectable  viral entry into  sorted tonsil 
DCs  occurred with Ba-L and  676  but not by IIIb and  228 
Figure 4.  Both NSI and SI isolates of HIV-1 are transferred from virus- 
pulsed DCs to CD4+ T  cells but viral entry into DCs by NSI is greater. 
(A) Viral entry of macrophage~tropic  virus but not T  cell line tropic iso- 
lates into tonsil DCs was detected by PCR. Tonsil DCs (lane I), mac- 
rophages (lane 2), and the T cell line MT2 (lane 3) were pulsed with virus 
and cultured  for 36 h before PCR. (B) Virus production in cocultures of 
DCs pulsed with SI isolates (IIIb and  228) and  macrophage-tropic  NSI 
isolates (Ba-L and 676) was measured by RT. Triphcate  cultures to which 
allogeneic T  cells had been added  immediately  (0 h) were compared  to 
cultures to which T cells were added after culturing the DCs after the vi- 
rus pulse (24 h).  (C) Transfer of Ba-L from virus-pulsed  tonsil DCs was 
reduced  if the DCs were cultured for 24 h before addition ofT cells or if 
the DCs were preincubated  with AZT (30 ~M for 3 h) and virus added 
in the presence  of AZT. DCs pulsed with lower concentration  of virus 
(1,000 TCID50  ) had reduced virus production. 
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an MLR was found with all strains. After the virus-pulsed 
DCs  were  cultured  for  24  h,  transmission  occurred,  but 
tLT production  was  reduced  (Fig.  4  13). Proliferative re- 
sponses  (12  h  [3H]thymidine  uptake  measured  after 4  d) 
were decreased by < 15% by 24 h  of culture of DCs. Re- 
duction of input virus and pretreatment with AZT also re- 
duced but did not eliminate virus production in the cocul- 
tures  (Fig.  4  C), suggesting that the infection of DCs was 
contributing to HIV-1 transmission, but carriage of virions 
as described for blood DCs  (6,  12)  also occurred.  During 
the virus pulse tight aggregates of DCs formed. Sequestra- 
tion of virions in these clusters may contribute to the ob- 
served transmission but it is unclear if this would occur in 
vivo and contribute to virus carriage. 
DCs and LCs process antigen peripherally and migrate to 
draining  lymph  nodes  or  spleen.  In  this  study  we  have 
shown preferential entry of macrophage-tropic, NSI, virus 
into CD4 lymphoid DCs from thymus and tonsil. If CD4- 
expressing DCs from other sites exhibit a similar profile of 
susceptibility,  preferential  infection  and  carriage  of mac- 
rophage-tropic  virus  from  sites  of HIV  exposure  to  re- 
sponding T  cells  in lymphoid tissue may explain the pre- 
dominance  of macrophage-tropic virus  during  the  initial 
viraemia of HIV-1 (27). 
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